期刊文献+

乳腺癌腋窝淋巴结转移的相关因素分析 被引量:3

Analysis of the relativity factor of metastasis in axillary lymph nodes in breast cancer
原文传递
导出
摘要 目的:探讨乳腺癌患者腋窝淋巴结转移的相关因素。方法:回顾性分析675例乳腺癌患者的病理资料,探讨雌激素受体、孕激素受体、人表皮生长因子受体表达规律并分析其与腋窝淋巴结转移的关系。结果:腋窝淋巴结阳性率43.72%,雌激素受体、孕激素受体、Ki-67蛋白阳性率分别为67.16%,71.12%,91.75%,人表皮生长因子受体过表达率14.19%。雌激素受体、孕激素受体、Ki-67蛋白、人表皮生长因子受体与淋巴结转移无相关性。结论:淋巴结转移与雌激素受体、孕激素受体、Ki-67蛋白、人表皮生长因子受体表达是相对独立、相互补充的乳腺癌预后因素。 Objective To explore the pathological characteristic of breast cancer. Methods The expression of C erbB-2, estrogen receptor and progesterone receptor and its relationship with axillary lymph nodes metastasis was retrospectively analyzed in 675 patients with breast neoplasms. Results The positive rate of invasion of axillary lymph nodes was 43. 72%. The positive rates of estrogen receptor, progesterone receptor and Ki-67 were 67. 16%, 71. 12% and 91. 75% respectively. The overexpression rate of C-erbB-2 was 14. 19%. Estrogen receptor, progesterone receptor, C-erbB-2 and Ki-67 were not correlated to metastasis of axillary lymph nodes. Conclusion Metastasis of lymph nodes is a relatively independent prognostic factor of breast cancer from estrogen receptor, progesterone receptor, C-erbB-2 and Ki-67.
出处 《中华实用诊断与治疗杂志》 2009年第7期669-670,共2页 Journal of Chinese Practical Diagnosis and Therapy
关键词 乳腺肿瘤 临床病理学 雌激素受体 孕激素受体 人表皮生长因子受体 KI-67 Breast neoplasms pathology estrogen receptor progesterone receptor C-erbB 2 Ki -67
  • 相关文献

参考文献9

二级参考文献44

  • 1王中华,徐兵河.129例30岁以下女性乳腺癌的临床特点及预后分析[J].中华肿瘤杂志,2005,27(2):111-113. 被引量:40
  • 2刘尚廉.乳腺癌雌激素受体的酶联雌二醇组化检测法[J].肿瘤,1986,6:104-104. 被引量:1
  • 3Kamb A, Gruis NA, Weaver F. A cell cycle regulator potentially involved in genesis of many tumor types. Science , 1994,264:436-441. 被引量:1
  • 4Quesnel B, Fenanx P, Phippe N ,et al. Analysis of p16 gene detection and point mutation in breast carcinoma. Br J Cancer, 1995,72:555-557. 被引量:1
  • 5Levine AJ, Momand J, Finlay CA, et al. The p53 tumor susspression gene. Nature , 1991, 351: 453-456. 被引量:1
  • 6Schmitt FC, Leal C, Lopes C. P53 protein expression and nuclear DNA content in breast introductal proliferation. J Patho, 1995,176:233-237. 被引量:1
  • 7Lawson JS,Field AS,Tran DD,et al.Breast cancer incidence and estrogen receptor alpha in normal mammary tissue-an epidemiologic study among Japanese women in Japan and Hawaii.Int J Cancer,2002,97(5):685-687 被引量:1
  • 8Norberg T,Klaar S,Karf G,et al.Imcreased p53 nutation frequency during tumor progression-results from a breast cancer cohort.Cancer Res,2001,61(22):8317-8321 被引量:1
  • 9Jukkola A,Bloigu R,Soini Y,et al.c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease.Eur J Cancer,2001,37(3):347-354 被引量:1
  • 10Beeken SW,Grizzle WE,Crowe DR,et al.Molecular biomarkers for breast cancer prognosis:coexpression of c-erbB-2 and p53.Ann Surg,2001,233(5):630-638 被引量:1

共引文献114

同被引文献27

  • 1张艳华,李洁冰,王雷.乳腺大汗腺癌超声表现1例[J].中华超声影像学杂志,2005,14(11):846-846. 被引量:14
  • 2Celis J E, Gromova I, Gromov P, etal. Molecular pathology of breast carcinomas: a protein expression signature specific for benign apocrine metaplasia[J]. FEBS Lett, 2006,580 (12) : 2935- 2944. 被引量:1
  • 3Matsuo K, Fukutomi T, Hasegawa T, et al. Histological and immunohistochemical analysis of apocrine breast carcinoma[J]. Breast Cancer,2002,9(1) :43- 49. 被引量:1
  • 4O'Malley F P, Bane A. An update on apocrine lesions of the breast[J]. Histopathology,2008,52(1):3 -10. 被引量:1
  • 5Tavassoli F A, Devilee P. World Health Organization classification of tumors. Pathology and genetics, tumors of the breast and female genital organs[M]. Lyon; IARC Press,2006: 35-37. 被引量:1
  • 6Leal C, Henrique R, Monteiro P, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers[J]. Hum Pathol, 2001,32(5): 487 -493. 被引量:1
  • 7Ogiya A, Horii R, Osako T, et al. Apoerine metaplasia of breast cancer: clinicopathological features and predicting response[J]. Breast Cancer,2010,17(4) :290- 297. 被引量:1
  • 8Bratthauer G L, Lininger R A, Man Y G, etal. Androgen and estrogen receptor mRNA status in apocrine carcinomas [ J]. Diagn Mol Pathol, 2002,11 (2) : 113-118. 被引量:1
  • 9Henderson T O, Amsterdam A, Bhatia S, et al. Systermatic review: surveillance for breast cancer in women treated with chest radiation for childhood adolescent, or young adult cancer [J]. Ann Intern Med,2010,152(7):444-455. 被引量:1
  • 10Kulka J, Tokes A M, Toth A I. Immunohistochemical phenotype of breast carcinoma predicts the effectiveness of primary systemic therapy[J]. Magy Onko1,2009,53(4):335-343. 被引量:1

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部